Presentation is loading. Please wait.

Presentation is loading. Please wait.

Relevance of Lymph Node Micrometastases in Radically Resected Endobronchial Carcinoid Tumors  Tommaso Claudio Mineo, MD, Gianluca Guggino, MD, Davide.

Published byAugustine Hunter Modified over 4 years ago

Similar presentations

Presentation on theme: "Relevance of Lymph Node Micrometastases in Radically Resected Endobronchial Carcinoid Tumors  Tommaso Claudio Mineo, MD, Gianluca Guggino, MD, Davide."— Presentation transcript:

1 Relevance of Lymph Node Micrometastases in Radically Resected Endobronchial Carcinoid Tumors 
Tommaso Claudio Mineo, MD, Gianluca Guggino, MD, Davide Mineo, MD, Gianluca Vanni, MD, Vincenzo Ambrogi, MD  The Annals of Thoracic Surgery  Volume 80, Issue 2, Pages (August 2005) DOI: /j.athoracsur Copyright © 2005 The Society of Thoracic Surgeons Terms and Conditions

2 Fig 1 Location of endobronchial carcinoid tumors.
The Annals of Thoracic Surgery  , DOI: ( /j.athoracsur ) Copyright © 2005 The Society of Thoracic Surgeons Terms and Conditions

3 Fig 2 Kaplan-Meier disease-free survival and log-rank test for patients with positive (N positive = pN1 + Nmi) and negative (N negative = N0) lymph node micrometastasis. Survivals with traditional pathologic nodal staging (pN0 and pN1) are also reported. The Annals of Thoracic Surgery  , DOI: ( /j.athoracsur ) Copyright © 2005 The Society of Thoracic Surgeons Terms and Conditions

4 Fig 3 Kaplan-Meier overall survival and log-rank test for patients with N positive (pN1 and pN1 + Nmi) and negative (pN0 and N0) lymph node micrometastasis. Survivals with traditional pathologic nodal staging (pN0 and pN1) are also reported. The Annals of Thoracic Surgery  , DOI: ( /j.athoracsur ) Copyright © 2005 The Society of Thoracic Surgeons Terms and Conditions

Download ppt "Relevance of Lymph Node Micrometastases in Radically Resected Endobronchial Carcinoid Tumors  Tommaso Claudio Mineo, MD, Gianluca Guggino, MD, Davide."

Similar presentations

Photodynamic Laser Therapy for Lesions in the Airway

Photodynamic Laser Therapy for Lesions in the Airway
Elizabeth A. David, MD, David T

Elizabeth A. David, MD, David T
Jeffrey L. Port, MD, Robert J. Korst, MD, Paul C. Lee, MD, Amanda L

Jeffrey L. Port, MD, Robert J. Korst, MD, Paul C. Lee, MD, Amanda L
Definitive or Preoperative Chemoradiation Therapy for Esophageal Cancer: Patterns of Care and Survival Outcomes  Meng S. Shao, MD, Andrew T. Wong, MD,

Definitive or Preoperative Chemoradiation Therapy for Esophageal Cancer: Patterns of Care and Survival Outcomes  Meng S. Shao, MD, Andrew T. Wong, MD,
Treating Constrictive Pericarditis in a Chinese Single-Center Study: A Five-Year Experience  Yiyun Lin, MD, Mi Zhou, MMS, Jian Xiao, MD, Bin Wang, MD,

Treating Constrictive Pericarditis in a Chinese Single-Center Study: A Five-Year Experience  Yiyun Lin, MD, Mi Zhou, MMS, Jian Xiao, MD, Bin Wang, MD,
Number of Lymph Nodes and Metastatic Lymph Node Ratio Are Associated With Survival in Lung Cancer  Chukwumere E. Nwogu, MD, Adrienne Groman, MA, Daniel.

Number of Lymph Nodes and Metastatic Lymph Node Ratio Are Associated With Survival in Lung Cancer  Chukwumere E. Nwogu, MD, Adrienne Groman, MA, Daniel.
Melanie Subramanian, MD, Timothy McMurry, PhD, Bryan F

Melanie Subramanian, MD, Timothy McMurry, PhD, Bryan F
Quality of life after tailored combined surgery for stage I non–small-cell lung cancer and severe emphysema  Eugenio Pompeo, MD, Enrico De Dominicis,

Quality of life after tailored combined surgery for stage I non–small-cell lung cancer and severe emphysema  Eugenio Pompeo, MD, Enrico De Dominicis,
Missed Intrapulmonary Lymph Node Metastasis and Survival After Resection of Non- Small Cell Lung Cancer  Matthew P. Smeltzer, PhD, Nicholas Faris, MDiv,

Missed Intrapulmonary Lymph Node Metastasis and Survival After Resection of Non- Small Cell Lung Cancer  Matthew P. Smeltzer, PhD, Nicholas Faris, MDiv,
Zhiqiang Xue, MD, Fengying Wu, MD, Karlyn E

Zhiqiang Xue, MD, Fengying Wu, MD, Karlyn E
Phillips B. Harrington, MD, William W. McAlexander, MD, Ayesha S

Phillips B. Harrington, MD, William W. McAlexander, MD, Ayesha S
Elliot Wakeam, MD, MPH, Meredith Giuliani, MBBS, MEd, Natasha B

Elliot Wakeam, MD, MPH, Meredith Giuliani, MBBS, MEd, Natasha B
Tumor Necrosis as a Prognostic Factor for Stage IA Non-Small Cell Lung Cancer  Seong Yong Park, MD, Hyun-Sung Lee, MD, PhD, Hee-Jin Jang, MD, Geon Kook.

Tumor Necrosis as a Prognostic Factor for Stage IA Non-Small Cell Lung Cancer  Seong Yong Park, MD, Hyun-Sung Lee, MD, PhD, Hee-Jin Jang, MD, Geon Kook.
Lisa M. Brown, MD, MAS, David T. Cooke, MD, Elizabeth A. David, MD 

Lisa M. Brown, MD, MAS, David T. Cooke, MD, Elizabeth A. David, MD 
Adjuvant Chemotherapy with 5-Fluorouracil and Cisplatin in Lymph Node-Positive Thoracic Esophageal Squamous Cell Carcinoma  Jeeyun Lee, MD, Kyoung-Eun.

Adjuvant Chemotherapy with 5-Fluorouracil and Cisplatin in Lymph Node-Positive Thoracic Esophageal Squamous Cell Carcinoma  Jeeyun Lee, MD, Kyoung-Eun.
Log Odds of Positive Lymph Nodes Predicts Survival in Patients After Resection for Esophageal Cancer  Jinlin Cao, MD, Ping Yuan, MD, Honghai Ma, MD, Peng.

Log Odds of Positive Lymph Nodes Predicts Survival in Patients After Resection for Esophageal Cancer  Jinlin Cao, MD, Ping Yuan, MD, Honghai Ma, MD, Peng.
Prognostic Factors and Analysis of Microsatellite Instability in Resected Pulmonary Metastases From Colorectal Carcinoma  Giulio Melloni, MD, Claudio.

Prognostic Factors and Analysis of Microsatellite Instability in Resected Pulmonary Metastases From Colorectal Carcinoma  Giulio Melloni, MD, Claudio.
Morbidity, Survival, and Site of Recurrence After Mediastinal Lymph-Node Dissection Versus Systematic Sampling After Complete Resection for Non-Small.

Morbidity, Survival, and Site of Recurrence After Mediastinal Lymph-Node Dissection Versus Systematic Sampling After Complete Resection for Non-Small.
Benjamin E. Lee, MD, Mark Shapiro, MD, John R. Rutledge, MAS, Robert J

Benjamin E. Lee, MD, Mark Shapiro, MD, John R. Rutledge, MAS, Robert J
Osteopontin Combined With CD44v6, a Novel Prognostic Biomarker in Non-Small Cell Lung Cancer Undergoing Curative Resection  Bing-sheng Sun, MD, PhD, Yue.

Osteopontin Combined With CD44v6, a Novel Prognostic Biomarker in Non-Small Cell Lung Cancer Undergoing Curative Resection  Bing-sheng Sun, MD, PhD, Yue.

Similar presentations

Ads by Google